240 related articles for article (PubMed ID: 26366562)
1. Absolute Reticulocyte Count Acts as a Surrogate for Fetal Hemoglobin in Infants and Children with Sickle Cell Anemia.
Meier ER; Byrnes C; Weissman M; Lee YT; Miller JL
PLoS One; 2015; 10(9):e0136672. PubMed ID: 26366562
[TBL] [Abstract][Full Text] [Related]
2. Reticulocyte parameters and hemoglobin F production in sickle cell disease patients undergoing hydroxyurea therapy.
Borba R; Lima CS; Grotto HZ
J Clin Lab Anal; 2003; 17(2):66-72. PubMed ID: 12640630
[TBL] [Abstract][Full Text] [Related]
3. Examination of Reticulocytosis among Chronically Transfused Children with Sickle Cell Anemia.
Kaushal M; Byrnes C; Khademian Z; Duncan N; Luban NL; Miller JL; Fasano RM; Meier ER
PLoS One; 2016; 11(4):e0153244. PubMed ID: 27116614
[TBL] [Abstract][Full Text] [Related]
4. Fetal hemoglobin and F-cell responses to long-term hydroxyurea treatment in young sickle cell patients. The French Study Group on Sickle Cell Disease.
Maier-Redelsperger M; de Montalembert M; Flahault A; Neonato MG; Ducrocq R; Masson MP; Girot R; Elion J
Blood; 1998 Jun; 91(12):4472-9. PubMed ID: 9616141
[TBL] [Abstract][Full Text] [Related]
5. Predictors of fetal hemoglobin response in children with sickle cell anemia receiving hydroxyurea therapy.
Ware RE; Eggleston B; Redding-Lallinger R; Wang WC; Smith-Whitley K; Daeschner C; Gee B; Styles LA; Helms RW; Kinney TR; Ohene-Frempong K
Blood; 2002 Jan; 99(1):10-4. PubMed ID: 11756146
[TBL] [Abstract][Full Text] [Related]
6. Reference values and hematologic changes from birth to 5 years in patients with sickle cell disease. Cooperative Study of Sickle Cell Disease.
Brown AK; Sleeper LA; Miller ST; Pegelow CH; Gill FM; Waclawiw MA
Arch Pediatr Adolesc Med; 1994 Aug; 148(8):796-804. PubMed ID: 7519102
[TBL] [Abstract][Full Text] [Related]
7. Physiologic decline in fetal hemoglobin parameters in infants with sickle cell disease: implications for pharmacological intervention.
Marcus SJ; Ware RE
J Pediatr Hematol Oncol; 1999; 21(5):407-11. PubMed ID: 10524455
[TBL] [Abstract][Full Text] [Related]
8. Variation in fetal hemoglobin parameters and predicted hemoglobin S polymerization in sickle cell children in the first two years of life: Parisian Prospective Study on Sickle Cell Disease.
Maier-Redelsperger M; Noguchi CT; de Montalembert M; Rodgers GP; Schechter AN; Gourbil A; Blanchard D; Jais JP; Ducrocq R; Peltier JY
Blood; 1994 Nov; 84(9):3182-8. PubMed ID: 7524767
[TBL] [Abstract][Full Text] [Related]
9. Not all red cells sickle the same: Contributions of the reticulocyte to disease pathology in sickle cell anemia.
Carden MA; Fasano RM; Meier ER
Blood Rev; 2020 Mar; 40():100637. PubMed ID: 31735458
[TBL] [Abstract][Full Text] [Related]
10. Fetal Hemoglobin is Associated with Peripheral Oxygen Saturation in Sickle Cell Disease in Tanzania.
Nkya S; Mgaya J; Urio F; Makubi A; Thein SL; Menzel S; Cox SE; Newton CR; Kirkham FJ; Mmbando BP; Makani J
EBioMedicine; 2017 Sep; 23():146-149. PubMed ID: 28844412
[TBL] [Abstract][Full Text] [Related]
11. Expression patterns of fetal hemoglobin in sickle cell erythrocytes are both patient- and treatment-specific during childhood.
Meier ER; Byrnes C; Weissman M; Noel P; Luban NL; Miller JL
Pediatr Blood Cancer; 2011 Jan; 56(1):103-9. PubMed ID: 21108444
[TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of erythrocytes containing fetal hemoglobin (F cells) in children with sickle cell disease.
Marcus SJ; Kinney TR; Schultz WH; O'Branski EE; Ware RE
Am J Hematol; 1997 Jan; 54(1):40-6. PubMed ID: 8980259
[TBL] [Abstract][Full Text] [Related]
13. Hydroxyurea alters hematological, biochemical and inflammatory biomarkers in Brazilian children with SCA: Investigating associations with βS haplotype and α-thalassemia.
Yahouédéhou SCMA; da Guarda CC; Figueiredo CVB; Santiago RP; Carvalho SP; Fiuza LM; Ndidi US; Oliveira RM; Carvalho MOS; Nascimento VML; Rocha LC; Lyra IM; Adorno EV; Goncalves MS
PLoS One; 2019; 14(7):e0218040. PubMed ID: 31306416
[TBL] [Abstract][Full Text] [Related]
14. Functional polymorphisms of BCL11A and HBS1L-MYB genes affect both fetal hemoglobin level and clinical outcomes in a cohort of children with sickle cell anemia.
Sales RR; Belisário AR; Faria G; Mendes F; Luizon MR; Viana MB
Ann Hematol; 2020 Jul; 99(7):1453-1463. PubMed ID: 32447424
[TBL] [Abstract][Full Text] [Related]
15. Reticulocytosis and anemia are associated with an increased risk of death and stroke in the newborn cohort of the Cooperative Study of Sickle Cell Disease.
Meier ER; Wright EC; Miller JL
Am J Hematol; 2014 Sep; 89(9):904-6. PubMed ID: 24891147
[TBL] [Abstract][Full Text] [Related]
16. Early Reticulocytosis and Anemia Are Associated with Abnormal and Conditional Transcranial Doppler Velocities in Children with Sickle Cell Anemia.
Meier ER; Fasano RM; Estrada M; He J; Luban NL; McCarter R
J Pediatr; 2016 Feb; 169():227-31.e1. PubMed ID: 26593107
[TBL] [Abstract][Full Text] [Related]
17. A systematic review of the literature for severity predictors in children with sickle cell anemia.
Meier ER; Fasano RM; Levett PR
Blood Cells Mol Dis; 2017 Jun; 65():86-94. PubMed ID: 28185829
[TBL] [Abstract][Full Text] [Related]
18. Spectrum of fetal hemoglobin responses in sickle cell patients treated with hydroxyurea: the National Institutes of Health experience.
Rodgers GP
Semin Oncol; 1992 Jun; 19(3 Suppl 9):67-73. PubMed ID: 1379375
[TBL] [Abstract][Full Text] [Related]
19. Maintenance of elevated fetal hemoglobin levels by decitabine during dose interval treatment of sickle cell anemia.
DeSimone J; Koshy M; Dorn L; Lavelle D; Bressler L; Molokie R; Talischy N
Blood; 2002 Jun; 99(11):3905-8. PubMed ID: 12010787
[TBL] [Abstract][Full Text] [Related]
20. Production of erythrocytes that contain fetal hemoglobin in anemia. Transient in vivo changes.
Dover GJ; Boyer SH; Zinkham WH
J Clin Invest; 1979 Feb; 63(2):173-6. PubMed ID: 429549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
